Improvement in early urinary continence recovery after robotic-assisted radical prostatectomy based on postoperative pelvic anatomic features: a retrospective review.


Journal

BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571

Informations de publication

Date de publication:
18 Sep 2019
Historique:
received: 22 05 2018
accepted: 04 09 2019
entrez: 20 9 2019
pubmed: 20 9 2019
medline: 7 3 2020
Statut: epublish

Résumé

We investigated the impact of postoperative membranous urethral length and other anatomic characteristics of the pelvic floor shape as measured by magnetic resonance imaging on the improvement in continence following robotic-assisted radical prostatectomy. We retrospectively reviewed data from 73 patients who underwent postoperative prostate magnetic resonance imaging following robotic-assisted radical prostatectomy between 2013 and 2018. Patient demographics; pre-, peri-, and post-operative parameters; and pelvic anatomic features on magnetic resonance imaging were reviewed. Patients who used no urinary incontinence pads or pads for protection were considered to have achieved complete continence. Urinary continence was restored in 27.4, 53.4, 68.5, and 84.9% of patients at 1, 3, 6, and 12 months after robotic-assisted radical prostatectomy, respectively. When patients were divided into early and late continence groups based on urinary continence at 3 months after robotic-assisted radical prostatectomy, no significantly different clinical characteristics or surgical outcomes were found. However, the mean membranous urethral length (18.5 mm for the early continence group vs. 16.9 mm for the late continence group), levator muscle width (7.1 vs. 6.5 mm, respectively), and bladder neck width on the trigone side (7.2 mm vs. 5.4 mm, respectively) were significantly different between groups (all p < 0.05). Multivariate logistic regression analysis showed that membranous urethral length (odds ratio, 1.227; 95% confidence interval, 1.011-1.489; p = 0.038) and bladder neck width (odds ratio, 1.585; 95% confidence interval, 1.050-2.393; p = 0.028) were associated with the period of early urinary continence. Postoperative membranous urethral length and bladder neck width were significantly associated with early urinary continence recovery after robotic-assisted radical prostatectomy. It is highly recommended that surgeons focus on preserving the membranous urethral length and increasing the bladder neck width on the trigone side during surgery to achieve optimal continence outcomes after robotic-assisted radical prostatectomy.

Sections du résumé

BACKGROUND BACKGROUND
We investigated the impact of postoperative membranous urethral length and other anatomic characteristics of the pelvic floor shape as measured by magnetic resonance imaging on the improvement in continence following robotic-assisted radical prostatectomy.
METHODS METHODS
We retrospectively reviewed data from 73 patients who underwent postoperative prostate magnetic resonance imaging following robotic-assisted radical prostatectomy between 2013 and 2018. Patient demographics; pre-, peri-, and post-operative parameters; and pelvic anatomic features on magnetic resonance imaging were reviewed. Patients who used no urinary incontinence pads or pads for protection were considered to have achieved complete continence.
RESULTS RESULTS
Urinary continence was restored in 27.4, 53.4, 68.5, and 84.9% of patients at 1, 3, 6, and 12 months after robotic-assisted radical prostatectomy, respectively. When patients were divided into early and late continence groups based on urinary continence at 3 months after robotic-assisted radical prostatectomy, no significantly different clinical characteristics or surgical outcomes were found. However, the mean membranous urethral length (18.5 mm for the early continence group vs. 16.9 mm for the late continence group), levator muscle width (7.1 vs. 6.5 mm, respectively), and bladder neck width on the trigone side (7.2 mm vs. 5.4 mm, respectively) were significantly different between groups (all p < 0.05). Multivariate logistic regression analysis showed that membranous urethral length (odds ratio, 1.227; 95% confidence interval, 1.011-1.489; p = 0.038) and bladder neck width (odds ratio, 1.585; 95% confidence interval, 1.050-2.393; p = 0.028) were associated with the period of early urinary continence.
CONCLUSIONS CONCLUSIONS
Postoperative membranous urethral length and bladder neck width were significantly associated with early urinary continence recovery after robotic-assisted radical prostatectomy. It is highly recommended that surgeons focus on preserving the membranous urethral length and increasing the bladder neck width on the trigone side during surgery to achieve optimal continence outcomes after robotic-assisted radical prostatectomy.

Identifiants

pubmed: 31533678
doi: 10.1186/s12894-019-0519-8
pii: 10.1186/s12894-019-0519-8
pmc: PMC6751577
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

87

Références

J Urol. 2006 Jun;175(6):2201-6
pubmed: 16697841
Eur Urol. 2007 Apr;51(4):996-1003
pubmed: 17079070
J Urol. 2007 Jul;178(1):208-11
pubmed: 17499806
Urology. 2007 Jun;69(6):1157-60
pubmed: 17572206
J Urol. 2008 Sep;180(3):1018-23
pubmed: 18639300
Eur Urol. 2009 Mar;55(3):629-37
pubmed: 18801612
BJU Int. 2009 Jul;104(2):274-81
pubmed: 19594519
Can J Urol. 2010 Jun;17(3):5200-5
pubmed: 20566014
J Urol. 2010 Sep;184(3):1028-33
pubmed: 20643426
Eur Urol. 2011 May;59(5):702-7
pubmed: 21296482
Eur Urol. 2011 Jun;59(6):985-96
pubmed: 21458914
J Endourol. 2011 Jun;25(6):1025-30
pubmed: 21568755
J Urol. 2011 Jul;186(1):204-8
pubmed: 21575975
J Urol. 2012 Mar;187(3):945-50
pubmed: 22264458
Eur Urol. 2012 Sep;62(3):405-17
pubmed: 22749852
Eur Urol. 2014 Mar;65(3):610-9
pubmed: 23245815
Int J Urol. 2013 Nov;20(11):1052-63
pubmed: 23841851
J Endourol. 2014 Aug;28(8):930-8
pubmed: 24739066
J Endourol. 2015 Jun;29(6):683-90
pubmed: 25347698
BJU Int. 2015 Oct;116(4):577-83
pubmed: 25682782
Eur Urol. 2016 Mar;69(3):485-95
pubmed: 26297603
Can Urol Assoc J. 2017 Mar-Apr;11(3-4):E93-E99
pubmed: 28360954
J Endourol. 2017 Dec;31(12):1251-1257
pubmed: 29061068
Eur Urol. 1995;28(3):202-8
pubmed: 8536773
J Urol. 1998 Oct;160(4):1301-6
pubmed: 9751340

Auteurs

Akihiro Nakane (A)

Department of Urology, The Aichi Prefectural Federation of Agricultural Cooperatives for Health and Welfare Kainan Hospital, Yatomi, Japan. aki-nakane@ams.odn.ne.jp.
Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. aki-nakane@ams.odn.ne.jp.

Hiroki Kubota (H)

Department of Urology, The Aichi Prefectural Federation of Agricultural Cooperatives for Health and Welfare Kainan Hospital, Yatomi, Japan.
Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Yusuke Noda (Y)

Department of Urology, The Aichi Prefectural Federation of Agricultural Cooperatives for Health and Welfare Kainan Hospital, Yatomi, Japan.
Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Tomoki Takeda (T)

Department of Urology, The Aichi Prefectural Federation of Agricultural Cooperatives for Health and Welfare Kainan Hospital, Yatomi, Japan.
Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Yasuhiko Hirose (Y)

Department of Urology, The Aichi Prefectural Federation of Agricultural Cooperatives for Health and Welfare Kainan Hospital, Yatomi, Japan.
Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Atsushi Okada (A)

Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Kentaro Mizuno (K)

Department of Pediatric Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Noriyasu Kawai (N)

Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Keiichi Tozawa (K)

Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Yutaro Hayashi (Y)

Department of Pediatric Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Takahiro Yasui (T)

Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH